Recent News

• 10.21.2025 - Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
• 10.17.2025 - Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
• 08.11.2025 - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference
• 08.06.2025 - Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis
• 07.22.2025 - Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis
• 05.29.2025 - Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Recent Filings

• 10.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.21.2025 - EX-99.1 EX-99.1
• 10.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.17.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.14.2025 - EX-99.1 EX-99.1
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - EX-99.1 EX-99.1